Found: 5
Select item for more details and to access through your institution.
The Abca7<sup>V1613M</sup> variant reduces Aβ generation, plaque load, and neuronal damage.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 7, p. 4914, doi. 10.1002/alz.13783
- By:
- Publication type:
- Article
BIN1<sup>K358R</sup> suppresses glial response to plaques in mouse model of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 2922, doi. 10.1002/alz.13767
- By:
- Publication type:
- Article
A CLU/APOJ GWAS AD risk variant suppresses the astrocytic response to plaques and reduces axonal and neuritic damage in 5xFAD mice.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080373
- By:
- Publication type:
- Article
A CLU/APOJ GWAS AD risk variant suppresses the astrocytic response to plaques and reduces axonal and neuritic damage in 5xFAD mice.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080373
- By:
- Publication type:
- Article
C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer's disease mouse model.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51163-6
- By:
- Publication type:
- Article